MedPath
Found 21 clinical trials|View Analysis
Sort by:

MDMA-Assisted Therapy for Pathological Narcissism

Early Phase 1
Recruiting
Conditions
Narcissism
Interventions
First Posted Date
2024-08-22
Last Posted Date
2024-08-28
Lead Sponsor
University of Washington
Target Recruit Count
12
Registration Number
NCT06565494
Locations
🇺🇸

University of Washington, Seattle, Washington, United States

Dose Optimization of MDMA-Assisted Therapy for PTSD

Phase 2
Not yet recruiting
Conditions
Posttraumatic Stress Disorder
Interventions
Drug: Midomafetamine
Behavioral: Psychotherapy
First Posted Date
2024-05-17
Last Posted Date
2024-05-17
Lead Sponsor
Bronx VA Medical Center
Target Recruit Count
60
Registration Number
NCT06418178

MDMA-assisted Therapy for Fibromyalgia

Early Phase 1
Not yet recruiting
Conditions
Fibromyalgia
First Posted Date
2023-10-04
Last Posted Date
2024-04-12
Lead Sponsor
Spaulding Rehabilitation Hospital
Target Recruit Count
20
Registration Number
NCT06066853
Locations
🇺🇸

Massachusetts General Hospital, Charlestown, Massachusetts, United States

Perceptions of MDMA-Assisted Therapy Among Veterans With PTSD

Completed
Conditions
Post Traumatic Stress Disorder
First Posted Date
2023-06-08
Last Posted Date
2023-06-22
Lead Sponsor
Albany Research Institute, Inc.
Target Recruit Count
30
Registration Number
NCT05895318
Locations
🇺🇸

Stratton VA Medical Center, Albany, New York, United States

MDMA-assisted Therapy Versus Cognitive Processing Therapy for Veterans with Severe Posttraumatic Stress Disorder

Phase 2
Not yet recruiting
Conditions
PTSD
Interventions
Drug: MDMA
Behavioral: Cognitive Processing Therapy
Behavioral: MDMA-assisted Therapy
First Posted Date
2023-05-01
Last Posted Date
2024-11-11
Lead Sponsor
Patricia Suppes
Target Recruit Count
30
Registration Number
NCT05837845
Locations
🇺🇸

VA Palo Alto Health Care System / Stanford University, Palo Alto, California, United States

MDMA-Assisted Therapy for Veterans With Moderate to Severe Post Traumatic Stress Disorder

Phase 2
Not yet recruiting
Conditions
Post Traumatic Stress Disorder
Interventions
First Posted Date
2023-03-30
Last Posted Date
2023-03-30
Lead Sponsor
Stephen Robert Marder
Target Recruit Count
40
Registration Number
NCT05790239
Locations
🇺🇸

VA Greater Los Angeles Healthcare System, Westwood campus, Los Angeles, California, United States

Preliminary Effectiveness of Individual and Group MDMA-assisted Therapy for Israeli Veterans With PTSD and Moral Injury.

Phase 2
Not yet recruiting
Conditions
Post Traumatic Stress Disorder
MDMA ('Ecstasy')
Moral Injury
First Posted Date
2023-02-16
Last Posted Date
2023-02-16
Lead Sponsor
HaEmek Medical Center, Israel
Target Recruit Count
60
Registration Number
NCT05732155

MDMA-assisted Prolonged Exposure Therapy for Comorbid Alcohol Use Disorder and Post-traumatic Stress Disorder

Phase 2
Recruiting
Conditions
Post-traumatic Stress Disorder
PTSD
Alcohol Use Disorder
Alcohol Dependence
Comorbidities and Coexisting Conditions
Interventions
Behavioral: Prolonged exposure therapy
Drug: MDMA
Drug: Niacin
First Posted Date
2023-02-02
Last Posted Date
2023-11-07
Lead Sponsor
University of Sydney
Target Recruit Count
120
Registration Number
NCT05709353
Locations
🇦🇺

Turning Point, Richmond, Victoria, Australia

🇦🇺

Drug Health Services, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia

MDMA-assisted Therapy for Adjustment Disorder (AD) in Dyads of Patients With Cancer and a Concerned Significant Other

Phase 2
Recruiting
Conditions
Cancer
Adjustment Disorders
Interventions
First Posted Date
2022-10-18
Last Posted Date
2022-10-18
Lead Sponsor
Sunstone Medical
Target Recruit Count
20
Registration Number
NCT05584826
Locations
🇺🇸

Sunstone Medical, PC, Rockville, Maryland, United States

MDMA-Assisted Therapy for Stress Disorders in Healthcare Workers

Phase 2
Not yet recruiting
Conditions
Post-Traumatic Stress Disorder
Adjustment Disorders
Interventions
First Posted Date
2022-07-13
Last Posted Date
2024-11-20
Lead Sponsor
Willa Hall
Target Recruit Count
30
Registration Number
NCT05455996
© Copyright 2025. All Rights Reserved by MedPath